Autonomous Carcinogenic Potency Categorization Approach for Nitrosamine Drug Substance-related Impurities

22 September 2023, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Nitrosamine drug substance-related impurities (NDSRIs), which are compounds that can form during certain drug manufacturing processes and have been shown to cause cancer, assessing and mitigating their formation has become an important public health issue as evidenced by recent guidelines from health authorities like the FDA and EMA that provide acceptable intake limits for various N-nitrosamines. We have developed a web-based application that can autonomously analyze the N-nitrosamine risk category of compounds from their SMILES notation, providing instant screening to identify high-risk formations of N-nitrosamines. The accuracy of the tool was validated using an FDA dataset of compounds with known N-nitrosamine risks, as this algorithm rapidly and accurately categorized over 6000 chemicals' risks and comparison to the dataset labels showed high agreement, indicating it can quickly and reliably analyze large datasets. Further analysis revealing high parent amine pKaH correlates to low N-nitrosamine risk and more correlations with other descriptors is being discussed. Overall, the application integrates computational and regulatory knowledge to advance both environmental and human health priorities.

Keywords

nitrosamine drug substance related impurities
Carcinogenic Potency Categorization Approach
in silico tool

Supplementary materials

Title
Description
Actions
Title
Supporting Information
Description
Additional information for nitrosamine pattern detection. Guidance to the usage of the in-silico tool, data analysis with detailed coding and failed structures are also included in this supporting information.
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.